OBJECTIVE: To highlight the usefulness of ultrasonographic measurement of fetal foot length in determining fetal gestational age. STUDY DESIGN: Prospective validation study PLACE AND DURATION OF STUDY: Radiology Department Combined Military Hospital Bahawalpur from 01July 2020 to 31Dec 2020. METHODOLOGY: Women referred from our obstetrics OPD for antenatal ultrasound between 16 to 40 weeks were scrutinized through inclusion and exclusion criteria for selection in the study. Record of their age, parity, gestational age by LMP and sonographic measurement of fetal foot length were endorsed on a study proforma. After the end of study period, the data was entered in SPSS version 20 to measure Pearson correlation coefficient and R2 values for highlighting the correlation between two variables. P value < 0.01 is taken as significant. RESULTS: A total of 153 patients were included in the study. Mean age of patients in our study is 28.64 years and second parity is most frequent being 41.8%. Data entered in SPSS version 20 for regression analysis. Pearson correlation coefficient (R) is 0.988 and R2 value is 0.977 (P- 0.000) which shows powerful linear correlation between our two variables. CONCLUSION: The results of our study shows excellent reliable linear correlation between fetal foot length and gestational age by LMP. Therefore, the fetal foot length so measured by ultrasonography can be used confidently for determination of gestational age in routine or when other ultrasonographic measurement parameters become unreliable. KEYWORDS: Fetal foot length, Gestational age, Ultrasonographic age estimation.
Background: Brain tumors arising in the brain are called primary brain tumors. The brain tumors could be meninges, glands, nerves or brain tissue. Although brain tumors comprise of a small number of all cancers, but are disproportionately responsible for cancer-related deaths. The neoplasms may be low grade, high grade, primary tumor or metastatic. Aim: To evaluate the experience of brain tumors in a tertiary care hospital. Place and duration of study: Department of Neurosurgery, CMH, Lahore from March 2021 to March 2022. Methodology: This descriptive study included 38 patients. Age of patients ranged between 26 to 70 years and both genders having primary and secondary (metastatic) brain tumors who were considered fit for surgery were included. Patients who were unfit for anesthesia or unwilling for operation were excluded. Diagnosis of brain tumors was made by histopathology. Results: Mean age was 46.18±12.17 years. Male patients were 25(65.8%) and 13(34.2%) were female. All patients 38(100%) had headache 31(82%) patient had seizures, focal weakness in 26(68.42%) patients and 3(7.89%) patients had urinary/fecal incontinence. Majority of patients 16(42.11%) had glioblastoma, meningioma in 8(21.05%) patients while 3(7.89%) patients had pituitary adenoma. 15(39.47%) patients had tumor in right frontal lobe, 8(21.05%) patients in left parietal lobe and 4(10.52%) patients had tumor in right parietal lobe. Out of 3 patients, 1(2.63%) had right CP angle tumor, 1(2.63%) had in sphenoid ridge tumor, 1(2.63%) had tumor in Tuberculum Sallea respectively. Conclusion: It is concluded that male population had more brain tumor and glioblastomawas the most common tumor. Keywords: Brain tumors, Headache, Glioblastoma, Meningioma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.